About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026
Article Date
February 26, 2026
This article is featured on another website.
Go to article
Related posts
Browse all articles
November 5, 2026
Chime Biologics and Y’s AC Announce Strategic Collaboration to Advance Anti-CD26 mAb in Refractory Cancers
November 5, 2026
Chime Biologics and Y’s AC Announce Strategic Collaboration to Advance Anti-CD26 mAb in Refractory Cancers
September 11, 2026
pharmaphorum – How today’s biotechs are helping us Stand up To Cancer
September 11, 2026
pharmaphorum – How today’s biotechs are helping us Stand up To Cancer